Hester Biosciences to acquire 50 % stake in Thrishool Exim, Tanzania
The consideration for the acquisition is US $ 2.25 million
The consideration for the acquisition is US $ 2.25 million
The company has operations in North America, Asia, and Europe,
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
This approval of shelf-life extension was based on the availability of additional stability data, which was submitted to CDSCO
The vaccine can be stored at 2 to 8 degrees celsius and traditional cold chain capabilities will suffice
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Since its inception, the company has either acquired or taken a majority stake in five companies
Subscribe To Our Newsletter & Stay Updated